End-of-Life Inpatient Palliative Care for Glioblastoma Multiforme: Lessons Learned from One Case

Zhi-Yuan Xiao; Yan-Xia Sun; Dong-Rui Xu; Xiao-Hong Ning; Yu Wang; Yi Zhang; Wen-Bin Ma

doi:10.24920/004394

Your Location：

Home >

Browse articles >

End-of-Life Inpatient Palliative Care for Glioblastoma Multiforme: Lessons Learned from One Case

Chinese Medical Sciences Journal Vol. 39, Issue 4, Pages: 297-302(2024)

Case Report | Updated：2025-01-27

- End-of-Life Inpatient Palliative Care for Glioblastoma Multiforme: Lessons Learned from One Case
- Affiliations：
  
  1.Department of Neurosurgery
  2.Palliative Care Center; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing100730, China
- Author bio：
  
  Yi Zhang, E-mail: zhangyi780621@sina.com
  Wen-Bin Ma, E-mail: mawb2001@hotmail.com
- Funds：
- DOI：10.24920/004394
  CLC：
- Published：31 December 2024，
  
  Published Online：03 November 2024，
  
  Received：02 July 2024，
  
  Accepted：2024-09-14
- Accepted：
Scan QR Code
Xiao Zhi-Yuan,Sun Yan-Xia,Xu Dong-Rui,et al.End-of-Life Inpatient Palliative Care for Glioblastoma Multiforme: Lessons Learned from One Case[J].Chinese Medical Sciences Journal,2024,39(04):297-302.
DOI：

Xiao Zhi-Yuan,Sun Yan-Xia,Xu Dong-Rui,et al.End-of-Life Inpatient Palliative Care for Glioblastoma Multiforme: Lessons Learned from One Case[J].Chinese Medical Sciences Journal,2024,39(04):297-302. DOI： 10.24920/004394.

摘要

Abstract

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor with a poor prognosis and limited survival. Patients with GBM have a high demand for palliative care. In our present case

a 21-year-old female GBM patient received inpatient palliative care services including symptom management

mental and psychological support for the patient

psychosocial and clinical decision support for her family members

and pre- and post-death bereavement management for the family. Furthermore

we provided the family members with comprehensive psychological preparation for the patient's demise and assisted the patient's family throughout the mourning period.The aim of this study is to provide a reference and insights for the clinical implementation of palliative care for patients with malignant brain tumors.

关键词

Keywords

glioblastomaglioblastoma multiformepalliative careend-of-life care

references

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol2021; 23(8):1231-51. doi: 10.1111/bpa.13060http://dx.doi.org/10.1111/bpa.13060.

Luo C, Song K, Wu S, et al. The prognosis of glioblastoma: a large, multifactorial study. Br J Neurosurg2021; 35(5):555-61. doi: 10.1080/02688697.2021.1907306http://dx.doi.org/10.1080/02688697.2021.1907306.

Stylli SS. Novel treatment strategies for glioblastoma. Cancers (Basel)2020;12(10):2883. doi: 10.3390/cancers12102883http://dx.doi.org/10.3390/cancers12102883.

Gritsch S, Batchelor TT, Gonzalez Castro LN. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. Cancer2022;128(1):47-58. doi: 10.1002/cncr.33918http://dx.doi.org/10.1002/cncr.33918.

Stupp R, Brada M, van den Bent MJ, Tonn JC, et al. ESMO Guidelines Working Group. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol2014;25(Suppl 3): iii93-101. doi: 10.1093/annonc/mdu050http://dx.doi.org/10.1093/annonc/mdu050.

Huang B, Li X, Li Y, et al. Current immunotherapies for glioblastoma multiforme. Front Immunol2021; 11: 603911. doi: 10.3389/fimmu.2020.603911http://dx.doi.org/10.3389/fimmu.2020.603911.

Chen R, Cohen AL, Colman H. Targeted therapeutics in patients with high-grade gliomas: past, present, and future. Curr Treat Options Oncol2016;17(8): 42. doi: 10.1007/s11864-016-0418-0http://dx.doi.org/10.1007/s11864-016-0418-0.

Liu EK, Sulman EP, Wen PY, et al. Novel therapies for glioblastoma. Curr Neurol Neurosci Rep2020;20(7):19. doi: 10.1007/s11910-020-01042-6http://dx.doi.org/10.1007/s11910-020-01042-6.

Rominiyi O, Vanderlinden A, Clenton SJ, et al. Tumour treating fields therapy for glioblastoma: current advances and future directions. Br J Cancer2021; 124(4): 697-709. doi: 10.1038/s41416-020-01136-5http://dx.doi.org/10.1038/s41416-020-01136-5.

Liu P, Wang Y, Wang Y, et al. Effects of oncolytic viruses and viral vectors on immunity in glioblastoma. Gene Ther2022; 29(3-4):115-26. doi: 10.1038/s41434-020-00207-9http://dx.doi.org/10.1038/s41434-020-00207-9.

Witthayanuwat S, Pesee M, Supaadirek C, et al. Survival analysis of glioblastoma multiforme. Asian Pac J Cancer Prev2018;19(9):2613-7. doi: 10.22034/APJCP.2018.19.9.2613http://dx.doi.org/10.22034/APJCP.2018.19.9.2613.

Meissen H, Gong MN, Wong AI, et al. The future of critical care: optimizing technologies and a learning healthcare system to potentiate a more humanistic approach to critical care. Crit Care Explor2022; 4(3): e0659. doi: 10.1097/CCE.0000000000000659http://dx.doi.org/10.1097/CCE.0000000000000659.

Chung H, Harding R, Guo P. Palliative care in the Greater China region: a systematic review of needs, models, and outcomes. J Pain Symptom Manage2021; 61(3): 585-612. doi: 10.1016/j.jpainsymmanhttp://dx.doi.org/10.1016/j.jpainsymman.

Hui D, Bruera E. Models of palliative care delivery for patients with cancer. J Clin Oncol2020; 38(9): 852-65. doi: 10.1200/JCO.18.02123http://dx.doi.org/10.1200/JCO.18.02123.

Wee B. Models of delivering palliative and end-of-life care in the UK. Curr Opin Support Palliat Care2013; 7(2): 195-200. doi: 10.1097/SPC.0b013e328361570ahttp://dx.doi.org/10.1097/SPC.0b013e328361570a.

Vanbutsele G, van Belle S, Surmont V, et al. The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life: a randomised controlled trial. Eur J Cancer2020; 124: 186-93. doi: 10.1016/j.ejca.2019.11.009http://dx.doi.org/10.1016/j.ejca.2019.11.009.

Srinivasan VJ, Akhtar S, Huppertz JW, et al. Prospective cohort study on the impact of early versus late inpatient palliative care on length of stay and cost of care. Am J Hosp Palliat Care2023:10499091231152609. doi: 10.1177/10499091231152609http://dx.doi.org/10.1177/10499091231152609.

Byrne A, Torrens-Burton A, Sivell S, et al. Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers. Cochrane Database Syst Rev 2022; 1(1): CD013440. doi: 10.1002/14651858.CD013440.pub2http://dx.doi.org/10.1002/14651858.CD013440.pub2.

Golla H, Nettekoven C, Bausewein C, et al; EPCOG study group. Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol. BMJ Open2020;10(1):e034378. doi: 10.1136/bmjopen-2019-034378http://dx.doi.org/10.1136/bmjopen-2019-034378.

Ferrell BR, Temel JS, Temin S, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical practice guideline update. J Clin Oncol2017; 35(1): 96-112. doi: 10.1200/JCO.2016.70.1474http://dx.doi.org/10.1200/JCO.2016.70.1474.

Sizoo EM, Braam L, Postma TJ, et al. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol2010; 12(11): 1162-6. doi: 10.1093/neuonc/nop045http://dx.doi.org/10.1093/neuonc/nop045.

Tatum PE. End-of-Life Care: Hospice Care. FP Essent. 2020Nov;498:26-31.

Armstrong TS, Vera-Bolanos E, Acquaye AA, et al. The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms. Neuro Oncol2016; 18(2): 252-60. doi: 10.1093/neuonc/nov166http://dx.doi.org/10.1093/neuonc/nov166.

Koekkoek JA, Dirven L, Sizoo EM, et al. Symptoms and medication management in the end of life phase of high-grade glioma patients. J Neurooncol2014; 120(3): 589-95. doi: 10.1007/s11060-014-1591-2http://dx.doi.org/10.1007/s11060-014-1591-2.

WHO. WHO definition of palliative care (2018) [EB/OL]. Available at www.who.int/cancer/palliative/definition/en.www.who.int/cancer/palliative/definition/en. Accessed December 6, 2021.

International Association For Hospice & Palliative Care. IAHPC Projects: Consensus-Based Definition of Palliative Care (2019)[EB/OL]. Available at https:// hospicecare. com/ what-we-do/ projects/ consensus-based-definition-of-palliative-care/.https://hospicecare.com/what-we-do/projects/consensus-based-definition-of-palliative-care/. Accessed November 1, 2024.

Walbert T, Khan M. End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol 2014 Apr; 117(2): 217-24. doi: 10.1007/s11060-014-1393-6http://dx.doi.org/10.1007/s11060-014-1393-6.

Thier K, Calabek B, Tinchon A, et al. The last 10 days of patients with glioblastoma: assessment of clinical signs and symptoms as well as treatment. Am J Hosp Palliat Care2016; 33(10): 985-88. doi: 10.1177/1049909115609295http://dx.doi.org/10.1177/1049909115609295

Pace A, Dirven L, Koekkoek JAF, et al; European Association of Neuro-Oncology palliative care task force. European Association of Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol2017; 18(6): e330-40. doi: 10.1016/S1470-2045(17)30345-5http://dx.doi.org/10.1016/S1470-2045(17)30345-5.

Koekkoek JAF, van der Meer PB, Pace A, et al. Palliative care and end-of-life care in adults with malignant brain tumors. Neuro Oncol2022: noac216. doi: 10.1093/neuonc/noac216http://dx.doi.org/10.1093/neuonc/noac216.

Walbert T, Stec NE. Palliative care in brain tumors. Handb Clin Neurol2023; 191: 69-80. doi: 10.1016/B978-0-12-824535-4.00011-2http://dx.doi.org/10.1016/B978-0-12-824535-4.00011-2.

Oberndorfer S, Hutterer M. Palliative care in glioma management. Curr Opin Oncol2019; 31(6): 548-53. doi: 10.1097/CCO.0000000000000584http://dx.doi.org/10.1097/CCO.0000000000000584.

Xiao Z, Chen W, Zhao H, et al. Palliative care for patients with glioma: A recent scientometric analysis of the Web of Science in 2022. Front Oncol2022; 12: 995639. doi: 10.3389/fonc.2022.995639http://dx.doi.org/10.3389/fonc.2022.995639.

Kwak J, Haley WE. Current research findings on end-of-life decision making among racially or ethnically diverse groups. Gerontologist2005; 45(5): 634-41. doi: 10.1093/geront/45.5.634http://dx.doi.org/10.1093/geront/45.5.634.

Chu LW, Luk JK, Hui E, et al. Advance directive and end-of-life care preferences among Chinese nursing home residents in Hong Kong. J Am Med Dir Assoc2011; 12(2): 143-52. doi: 10.1016/j.jamda.2010.08.015http://dx.doi.org/10.1016/j.jamda.2010.08.015.

Yin Z, Li J, Ma K, et al. Development of palliative care in China: a tale of three cities. Oncologist2017; 22(11): 1362-67. doi: 10.1634/theoncologisthttp://dx.doi.org/10.1634/theoncologist.

Pompili A, Telera S, Villani V, et al. Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients. Neurosurg Focus2014; 37(6): E5. doi: 10.3171/2014.9.FOCUS14493http://dx.doi.org/10.3171/2014.9.FOCUS14493.

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰